Wallonia-BIOMED — HuMAb-S aureus — CER (Q4027002)
Jump to navigation
Jump to search
Project Q4027002 in Belgium
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Wallonia-BIOMED — HuMAb-S aureus — CER |
Project Q4027002 in Belgium |
Statements
615,451.18 Euro
0 references
1,538,627.94 Euro
0 references
40.0 percent
0 references
15 May 2014
0 references
31 December 2023
0 references
CER-Groupe
0 references
50°11'10.64"N, 5°17'59.03"E
0 references
6900
0 references
Développement d'un projet de recherche dans le domaine des anticorps monoclonaux humains à but thérapeutique utilisant le S.aureus comme modèle. (French)
0 references
Development of a research project in the field of therapeutic human monoclonal antibodies using S.aureus as a model. (English)
17 January 2022
0 references
Ontwikkeling van een onderzoeksproject op het gebied van therapeutische menselijke monoklonale antilichamen die S.aureus als model gebruiken. (Dutch)
18 January 2022
0 references
Entwicklung eines Forschungsprojekts auf dem Gebiet therapeutischer humaner monoklonaler Antikörper mit S.aureus als Modell. (German)
18 January 2022
0 references
Sviluppo di un progetto di ricerca nel campo degli anticorpi monoclonali umani terapeutici utilizzando S.aureus come modello. (Italian)
18 January 2022
0 references
Identifiers
WAL-874
0 references